Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.20%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +36.53%
#5 RedStone RedStone +30.12%
#6 Humanity Humanity +25.83%
#7 Codatta Codatta +22.55%
#8 Walrus Walrus +19.40%
#9 Enso Enso +18.53%
#10 The Black Bull The Black Bull +18.16%
Coin of the day
EXOD EXOD
Innstillinger
Språk
NORSK
Valuta
USD
Tema
ReShape Lifesciences Inc. ReShape Lifesciences Inc.

ReShape Lifesciences Inc.

RSLS
Rangering i aksjer #36770
Founded in 2002 and based in San Clemente, California, ReShape Lifesciences... Founded in 2002 and based in San Clemente, California, ReShape Lifesciences Inc. operates as a medical device company dedicated to addressing obesity and metabolic diseases. The company's market extends throughout the United States, Australia, Europe, and globally. Its diverse product lineup features the Lap-Band System, a minimally invasive, long-term solution for severe obesity that offers an alternative to more extensive surgical interventions like gastric bypass or sleeve gastrectomy. Under development is the ReShape Vest system, an investigational, minimally invasive device that is laparoscopically implanted around the stomach to assist obese and morbidly obese patients in losing weight, without cutting or permanently removing parts of the stomach or bypassing any section of the gastrointestinal tract. ReShape also supports patients through the ReShapeCare virtual health coaching program, a telehealth service aimed at promoting healthy lifestyle adjustments for individuals undergoing medically supervised weight management. Additionally, the company is conducting preclinical development for ReShape Diabetes Bloc-Stim Neuromodulation, a technology intended for the treatment of type 2 diabetes mellitus. Among its offerings is the Obalon Balloon System, a swallowable capsule used to monitor and display the balloon's exact position during its placement. The company, initially incorporated as EnteroMedics Inc., changed its name to ReShape Lifesciences Inc. in 2017.
Aksjekurs
$3.92
Sist synkronisert: 2025-08-14
Markedsverdi
$2.34M
Endring (1 dag)
-69.38%
Endring (1 år)
0.00%
Land
US
Handel ReShape Lifesciences Inc. (RSLS)

Kategori

Healthcare
Aksjeprishistorikk for ReShape Lifesciences Inc. (RSLS)
Høyeste sluttskurs: $9.27 den 2025-08-01

Laveste sluttskurs: $4.47M den 2019-04-01
Aksjeprishistorikk for ReShape Lifesciences Inc. fra 2019 til 2026
Årlig aksjeprisytelse
År Ytelse
2025 -98.06%
2024 -70.58%
2023 -96.02%
2022 -92.60%
2021 -59.08%
2020 -16.07%
2019 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $111.15 -15.64%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $339.00 -11.24%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $91.19 -1.97%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $51.77 -49.83%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $91.49 16.90%
US